Trexquant Investment’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-45,744
Closed -$822K 1836
2022
Q3
$822K Buy
+45,744
New +$730K 0.03% 606
2022
Q1
Sell
-12,676
Closed -$197K 1846
2021
Q4
$197K Buy
+12,676
New +$242K 0.01% 1156
2021
Q3
Sell
-17,466
Closed -$398K 1605
2021
Q2
$398K Buy
+17,466
New +$367K 0.03% 594
2021
Q1
Sell
-29,428
Closed -$813K 1577
2020
Q4
$813K Buy
+29,428
New +$573K 0.09% 306
2020
Q3
Sell
-37,987
Closed -$783K 1619
2020
Q2
$783K Buy
+37,987
New +$517K 0.05% 495
2020
Q1
Sell
-17,444
Closed -$271K 1510
2019
Q4
$271K Buy
17,444
+6,534
+60% +$65.9K 0.02% 783
2019
Q3
$57K Buy
+10,910
New +$80.9K ﹤0.01% 823

Other funds holding MYOV

Trexquant Investment's MYOV Position: Q4 2022 in Review

Trexquant Investment sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 45,744 shares — an estimated $822K sold.

Trexquant Investment first reported a position in MYOV in Q3 2019 and held it in 7 quarters. The position peaked at $822K in Q3 2022. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Trexquant Investment reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Trexquant Investment sold 45,744 Myovant Sciences Ltd. shares in Q4 2022, an estimated $822K.
  • Trexquant Investment first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 7 quarters.
  • Trexquant Investment's Myovant Sciences Ltd. position peaked at $822K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Trexquant Investment's 13F filing for Q4 2022, filed 13 Feb 2023.